Header Ads

Eli Lilly pharmaceutical company starts Phase 3 coronavirus trial with drug used to treat arthritis

June 17, 2020
Eli Lilly pharmaceutical company starts Phase 3 coronavirus trial with drug used to treat arthritis
By Kayla Rivas

The first patient has been enrolled in Eli Lilly’s Phase 3 clinical trial to test whether an arthritis drug, baricitinib, marketed as Olumiant, can treat hospitalized COVID-19 patients.





June 17, 2020 at 10:25PM
via FOX News read more...

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.